Scientists say measuring the levels of a brain-nourishing chemicals may be help them predict a schizophrenic patient's chance of suffering a relapse. According to a press release from Medical College of Georgia, for the next two-and-a-half years, researchers there will be measuring levels of brain-derived neurotrophic factor, or BDNF, in the blood of patients with schizophrenia to see if the pattern of their rise and fall is a good indicator that patients are at risk for a relapse. Scientists...
Read moreThe interplay between nature and nurture is a recurring theme in the debate over the development of schizophrenia or its relapse. The... Read more »
In the fall of 1992, my grandmother died. She was a widow—my grandpa was in a coma when I got sick, and he died while I was in the... Read more »
When I was a disc jockey, I'd mix intuitive segues: rock-n-roll and the blues, classical and punk. So, too, with my writing, I make... Read more »
1. People with schizophrenia progressively deteriorate over time. Reality: The symptoms often attenuate in later life and by one's... Read more »
My child was just diagnosed with schizophrenia. What should I be prepared for? Are there any tools as a caregiver that I can... Read more »
Source: ADAM Encyclopedia
During an episode of schizophrenia, you may need to stay in the hospital for safety reasons, and to receive basic needs such as food, rest, and... Read more »
Source: HealthCentral Encyclopedia
Article updated and reviewed by Christos Ballas, MD, Attenting Psychiatrist, Inpatient and Consult/Liaison Psychiatry, Hospital of the University of... Read more »
The U.S. Food and Drug Administration (FDA) has approved a sustained action form of the antipsychotic Invega for the treatment of schizophrenia.... Read more »
Drugmaker Johnson & Johnson has submitted an application to the U.S. Food and Drug Administration for Risperdal Consta to be used in patients who... Read more »
A new drug called asenapine has shown positive results in a new clinical trial, its maker has reported. According to a news release from drugmaker... Read more »